Mariano M. Boccia

ORCID: 0009-0003-1030-1851
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroscience and Neuropharmacology Research
  • Memory and Neural Mechanisms
  • Receptor Mechanisms and Signaling
  • Neuroendocrine regulation and behavior
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Nicotinic Acetylcholine Receptors Study
  • Stress Responses and Cortisol
  • Cholinesterase and Neurodegenerative Diseases
  • Neuropeptides and Animal Physiology
  • Pharmacological Effects and Toxicity Studies
  • Alzheimer's disease research and treatments
  • Sleep and Wakefulness Research
  • Memory Processes and Influences
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Neural and Behavioral Psychology Studies
  • Mental Health Research Topics
  • Epilepsy research and treatment
  • NF-κB Signaling Pathways
  • Immune Response and Inflammation
  • Child and Adolescent Psychosocial and Emotional Development
  • Phosphodiesterase function and regulation
  • Amino Acid Enzymes and Metabolism
  • Pharmacological Effects and Assays
  • Diverse academic and cultural studies
  • Medicinal Plants and Neuroprotection

University of Buenos Aires
2014-2024

Consejo Nacional de Investigaciones Científicas y Técnicas
2005-2020

Institute of Astronomy and Space Physics
2014

Institute for Medical Research
2014

Alzheimer's disease (AD) can be considered as a of memory in its initial clinical stages. Amyloid-β (Aβ) peptide accumulation is central to the initiation leading later intracellular neurofibrillary tangles (NFTs) cytoskeletal t

10.3233/jad-131076 article EN Journal of Alzheimer s Disease 2014-03-10

Sildenafil (1, 3, 10, and 30 mg/kg, intraperitoneally (i.p.)), a cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) inhibitor, facilitated retention performance of one-trial step-through inhibitor avoidance task, when administered to male Swiss mice immediately after training, as indicated by on test 48 h later. The dose-response curve was an inverted U in this dose range, although only the 3 mg/kg sildenafil produced significant effects. did not affect response...

10.1097/00008877-199912000-00004 article EN Behavioural Pharmacology 1999-12-01

Although it is generally accepted that memory consolidation requires regulation of gene expression, only a few transcription factors (TFs) have been clearly demonstrated to be specifically involved in this process. Increasing research data point the participation Rel/nuclear factor-kappaB (NF-kappaB) family TFs and neural plasticity. Here we found two independent inhibitors NF-kappaB induced impairment one-trial step-through inhibitory avoidance paradigm mice: post-training administration...

10.1111/j.1460-9568.2005.04126.x article EN European Journal of Neuroscience 2005-05-01

CF-1 male mice were trained in an inhibitory avoidance task using a high footshock (1,2 mA, 50 Hz, 1 sec) order to reduce the influence of extinction on retention performance. At 2, 7, 14, or 30 d after training, first test was performed and hemicholinium (HC-3, 1.0 μg/mice), specific inhibitor high-affinity choline uptake brain cholinergic neurons, given intracerebroventricularly immediately after. Twenty four hours treatment, tested during five consecutive days, each 24 h apart. Retention...

10.1101/lm.150306 article EN Learning & Memory 2006-05-01

In this article, we will review some behavioral, pharmacological and neurochemical studies from our laboratory on mice, which might contribute to understanding of the complex processes memory consolidation reconsolidation. We discuss post-training (memory consolidation) post-reactivation reconsolidation) effects icv infusions hemicholinium, a central inhibitor acetylcholine synthesis, intraperitoneal administration L-NAME, non-specific nitric oxide synthase, intrahippocampal injections an...

10.1590/s0100-879x2009000200001 article EN cc-by Brazilian Journal of Medical and Biological Research 2009-02-01
Coming Soon ...